{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:20:58Z","timestamp":1792704058902,"version":"4.5.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Viral infections are important contributors to exacerbation of asthma and chronic obstructive pulmonary disease; however, the role of viruses in the pathogenesis of idiopathic pulmonary fibrosis (IPF) is less clear. This likely reflects that fact that IPF acute exacerbations are defined clinically as \u201cnoninfectious,\u201d and little attention has been paid to the outcomes of patients with IPF with diagnosed infections. However, accumulating evidence suggests that infections (both bacterial and viral) may influence disease outcomes either as exacerbating agents or initiators of disease. Support for a viral role in disease initiation comes from studies demonstrating the presence of herpesviral DNA and epithelial cell stress in the lungs of asymptomatic relatives at risk for developing familial IPF. In addition, the number of studies that can associate viral (especially herpesviral) signatures in the lung with the development of IPF is steadily growing, and activated leukocyte signatures in patients with IPF provide further support for infectious processes driving IPF progression. Animal modeling has been used to better understand how a gamma herpesvirus infection can modulate the pathogenesis of lung fibrosis and has demonstrated that preceding infections appear to reprogram lung epithelial cells during latency to produce profibrotic factors, making the lung more susceptible to subsequent fibrotic insult, whereas exacerbations of existing fibrosis, or infections in susceptible hosts, involve active viral replication and are influenced by antiviral therapy. In addition, there is new evidence that bacterial burden in the lungs of patients with IPF may predict a poor prognosis.<\/jats:p>","DOI":"10.1513\/annalsats.201502-088aw","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T16:59:50Z","timestamp":1657645190000},"page":"S186-S192","source":"Crossref","is-referenced-by-count":98,"title":["Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation"],"prefix":"10.1093","volume":"12","author":[{"given":"Bethany B.","family":"Moore","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and"},{"name":"Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,1]]},"reference":[{"key":"2026012303374378700_bib1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.200906-0959OC","article-title":"Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis","volume":"181","author":"Fell","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis","volume":"174","author":"Raghu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1164\/rccm.201001-0049ED","article-title":"The age of idiopathic pulmonary fibrosis","volume":"181","author":"Collard","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.arbres.2013.03.011","article-title":"Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis","volume":"49","author":"Xaubet","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"2026012303374378700_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib6","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00005","article-title":"The clinical course of patients with idiopathic pulmonary fibrosis","volume":"142","author":"Martinez","year":"2005","journal-title":"Ann Intern Med"},{"key":"2026012303374378700_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1503\/cmaj.1030055","article-title":"Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment","volume":"171","author":"Khalil","year":"2004","journal-title":"CMAJ"},{"key":"2026012303374378700_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-1536-1-2","article-title":"Viruses as co-factors for the initiation or exacerbation of lung fibrosis","volume":"1","author":"Vannella","year":"2008","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2026012303374378700_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2013.00271","article-title":"Human T cell aging and the impact of persistent viral infections","volume":"4","author":"F\u00fcl\u00f6p","year":"2013","journal-title":"Front Immunol"},{"key":"2026012303374378700_bib10","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.41.6.2633-2640.2003","article-title":"Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis","volume":"41","author":"Tang","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2026012303374378700_bib11","doi-asserted-by":"crossref","first-page":"240805","DOI":"10.1155\/2011\/240805","article-title":"Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study","volume":"2011","author":"Egan","year":"2011","journal-title":"Pulm Med"},{"key":"2026012303374378700_bib12","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012303374378700_bib13","doi-asserted-by":"crossref","first-page":"e37708","DOI":"10.1371\/journal.pone.0037708","article-title":"The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"2026012303374378700_bib14","doi-asserted-by":"crossref","first-page":"205ra136","DOI":"10.1126\/scitranslmed.3005964","article-title":"Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis","volume":"5","author":"Herazo-Maya","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026012303374378700_bib15","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4049\/jimmunol.179.4.2592","article-title":"Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis","volume":"179","author":"Feghali-Bostwick","year":"2007","journal-title":"J Immunol"},{"key":"2026012303374378700_bib16","doi-asserted-by":"crossref","first-page":"e8959","DOI":"10.1371\/journal.pone.0008959","article-title":"CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis","volume":"5","author":"Gilani","year":"2010","journal-title":"PLoS ONE"},{"issue":"56","key":"2026012303374378700_bib17","article-title":"Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis","volume":"1","author":"Moore","year":"2014","journal-title":"Front Med"},{"key":"2026012303374378700_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm\/146.1.266","article-title":"Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus","volume":"146","author":"Ueda","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026012303374378700_bib19","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2026012303374378700_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/thx.51.3.315","article-title":"Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis","volume":"51","author":"Meliconi","year":"1996","journal-title":"Thorax"},{"key":"2026012303374378700_bib21","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1683","article-title":"Idiopathic pulmonary fibrosis and hepatitis C virus infection","volume":"148","author":"Irving","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2026012303374378700_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.coph.2006.11.014","article-title":"Adenovirus infections and lung disease","volume":"7","author":"Hayashi","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"2026012303374378700_bib23","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1183\/09031936.97.10071445","article-title":"Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction","volume":"10","author":"Kuwano","year":"1997","journal-title":"Eur Respir J"},{"key":"2026012303374378700_bib24","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1183\/09031936.97.10092040","article-title":"Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis","volume":"10","author":"Yonemaru","year":"1997","journal-title":"Eur Respir J"},{"key":"2026012303374378700_bib25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/rmed.2001.1151","article-title":"Infection of TT virus in patients with idiopathic pulmonary fibrosis","volume":"95","author":"Bando","year":"2001","journal-title":"Respir Med"},{"key":"2026012303374378700_bib26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1164\/rccm.201010-1752OC","article-title":"Viral infection in acute exacerbation of idiopathic pulmonary fibrosis","volume":"183","author":"Wootton","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/thx.52.10.888","article-title":"Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection","volume":"52","author":"Wangoo","year":"1997","journal-title":"Thorax"},{"key":"2026012303374378700_bib28","first-page":"67","article-title":"Human cytomegalovirus DNA level in patients with idiopathic pulmonary fibrosis","volume":"55","author":"Dworniczak","year":"2004","journal-title":"J Physiol Pharmacol"},{"key":"2026012303374378700_bib29","first-page":"123","article-title":"HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis","volume":"22","author":"Zam\u00f2","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012303374378700_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(84)90702-5","article-title":"Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association?","volume":"2","author":"Vergnon","year":"1984","journal-title":"Lancet"},{"key":"2026012303374378700_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1309\/0B06Y93EGE6TQ36Y","article-title":"The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis","volume":"119","author":"Magro","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"2026012303374378700_bib32","first-page":"134","article-title":"Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis","volume":"24","author":"Manika","year":"2007","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026012303374378700_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/07853890.2010.532151","article-title":"A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung","volume":"44","author":"Pulkkinen","year":"2012","journal-title":"Ann Med"},{"key":"2026012303374378700_bib34","doi-asserted-by":"crossref","first-page":"e27800","DOI":"10.1371\/journal.pone.0027800","article-title":"Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases","volume":"6","author":"Lasithiotaki","year":"2011","journal-title":"PLoS ONE"},{"key":"2026012303374378700_bib35","doi-asserted-by":"crossref","first-page":"e55715","DOI":"10.1371\/journal.pone.0055715","article-title":"Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"8","author":"Calabrese","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012303374378700_bib36","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1164\/ajrccm.159.4.9807077","article-title":"The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis","volume":"159","author":"Stewart","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/thorax.55.11.958","article-title":"Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis","volume":"55","author":"Tsukamoto","year":"2000","journal-title":"Thorax"},{"key":"2026012303374378700_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1164\/rccm.2103058","article-title":"A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis","volume":"166","author":"Kelly","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib39","first-page":"851","article-title":"Idiopathic pulmonary fibrosis is strongly associated with productive infection by herpesvirus saimiri. Modern Pathol","volume":"27","author":"Folcik","year":"2014"},{"key":"2026012303374378700_bib40","doi-asserted-by":"crossref","first-page":"L1119","DOI":"10.1152\/ajplung.00382.2007","article-title":"Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection","volume":"294","author":"Lawson","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012303374378700_bib41","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.mcp.0000176678.38539.9a","article-title":"Epstein-Barr-virus-induced interstitial lung disease","volume":"11","author":"Marzouk","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"2026012303374378700_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.201406-1162OC","article-title":"Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease","volume":"191","author":"Kropski","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.resinv.2013.07.005","article-title":"Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia","volume":"52","author":"Ushiki","year":"2014","journal-title":"Respir Investig"},{"key":"2026012303374378700_bib44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1590\/1414-431X20132885","article-title":"Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation","volume":"46","author":"Santos","year":"2013","journal-title":"Braz J Med Biol Res"},{"key":"2026012303374378700_bib45","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1007\/s11033-014-3345-9","article-title":"Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis","volume":"41","author":"Wu","year":"2014","journal-title":"Mol Biol Rep"},{"key":"2026012303374378700_bib46","doi-asserted-by":"crossref","first-page":"405876","DOI":"10.1155\/2013\/405876","article-title":"Rhinovirus-induced exacerbations of asthma and COPD","volume":"2013","author":"Hershenson","year":"2013","journal-title":"Scientifica"},{"key":"2026012303374378700_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmicb.2013.00293","article-title":"Virus-induced exacerbations in asthma and COPD","volume":"4","author":"Kurai","year":"2013","journal-title":"Front Microbiol"},{"key":"2026012303374378700_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1513\/pats.200601-005TK","article-title":"Classification and natural history of the idiopathic interstitial pneumonias","volume":"3","author":"Kim","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2026012303374378700_bib49","doi-asserted-by":"crossref","first-page":"e77754","DOI":"10.1371\/journal.pone.0077754","article-title":"Experimental induction of pulmonary fibrosis in horses with the gammaherpesvirus equine herpesvirus 5","volume":"8","author":"Williams","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012303374378700_bib50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/rccm.200905-0798OC","article-title":"Latent herpesvirus infection augments experimental pulmonary fibrosis","volume":"181","author":"Vannella","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1183\/09031936.02.00272902","article-title":"Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice","volume":"20","author":"Lok","year":"2002","journal-title":"Eur Respir J"},{"key":"2026012303374378700_bib52","doi-asserted-by":"crossref","first-page":"L274","DOI":"10.1152\/ajplung.00028.2010","article-title":"Latent infection by \u03b3herpesvirus stimulates profibrotic mediator release from multiple cell types","volume":"300","author":"Stoolman","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012303374378700_bib53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/gerona\/glr211","article-title":"Pulmonary fibrosis induced by \u03b3-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-\u03b2","volume":"67","author":"Naik","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026012303374378700_bib54","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1165\/rcmb.2011-0224OC","article-title":"Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis","volume":"46","author":"Torres-Gonz\u00e1lez","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012303374378700_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbmt.2014.12.004","article-title":"Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Uhlving","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026012303374378700_bib56","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.ajpath.2011.08.002","article-title":"Severe gammaherpesvirus-induced pneumonitis and fibrosis in syngeneic bone marrow transplant mice is related to effects of transforming growth factor-\u03b2","volume":"179","author":"Coomes","year":"2011","journal-title":"Am J Pathol"},{"key":"2026012303374378700_bib57","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.0901871","article-title":"Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant","volume":"184","author":"Coomes","year":"2010","journal-title":"J Immunol"},{"key":"2026012303374378700_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1164\/rccm.200708-1184OC","article-title":"Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus","volume":"177","author":"McMillan","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib59","doi-asserted-by":"crossref","first-page":"L219","DOI":"10.1152\/ajplung.00300.2013","article-title":"\u03b3-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis","volume":"307","author":"Ashley","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012303374378700_bib60","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/jvi.71.6.4278-4283.1997","article-title":"Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells","volume":"71","author":"Dutia","year":"1997","journal-title":"J Virol"},{"key":"2026012303374378700_bib61","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0002-9440(10)64683-4","article-title":"Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice","volume":"158","author":"Ebrahimi","year":"2001","journal-title":"Am J Pathol"},{"key":"2026012303374378700_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/sji.12176","article-title":"IFN\u03b3 and perforin cooperate to control infection and prevent fatal pathology during persistent gammaherpesvirus infection in mice","volume":"79","author":"Bartholdy","year":"2014","journal-title":"Scand J Immunol"},{"key":"2026012303374378700_bib63","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200610-1426OC","article-title":"Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice","volume":"175","author":"Mora","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303374378700_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1189\/jlb.0507270","article-title":"Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages","volume":"84","author":"Gangadharan","year":"2008","journal-title":"J Leukoc Biol"},{"key":"2026012303374378700_bib65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1165\/rcmb.2006-0121OC","article-title":"Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis","volume":"35","author":"Mora","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012303374378700_bib66","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2213-2600(14)70069-4","article-title":"Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study","volume":"2","author":"Han","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026012303374378700_bib67","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1164\/rccm.201403-0541OC","article-title":"The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis","volume":"190","author":"Molyneaux","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/Supplement_2\/S186\/66445307\/annalsats_12_supplement_2_s186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/Supplement_2\/S186\/66445307\/annalsats_12_supplement_2_s186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:38:04Z","timestamp":1769157484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/12\/Supplement_2\/S186\/8429196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,1]]},"references-count":67,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2015,11,1]]},"published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201502-088aw","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,11]]},"published":{"date-parts":[[2015,11,1]]}}}